City Holding Co’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12
Closed -$324 522
2022
Q4
$324 Hold
12
﹤0.01% 510
2022
Q3
$0 Hold
12
﹤0.01% 514
2022
Q2
$0 Hold
12
﹤0.01% 505
2022
Q1
$0 Hold
12
﹤0.01% 505
2021
Q4
$0 Hold
12
﹤0.01% 504
2021
Q3
$0 Hold
12
﹤0.01% 487
2021
Q2
$0 Hold
12
﹤0.01% 499
2021
Q1
$1K Hold
12
﹤0.01% 499
2020
Q4
$1K Hold
12
﹤0.01% 491
2020
Q3
$0 Hold
12
﹤0.01% 501
2020
Q2
$0 Hold
12
﹤0.01% 488
2020
Q1
$0 Hold
12
﹤0.01% 486
2019
Q4
$0 Hold
12
﹤0.01% 487
2019
Q3
$0 Hold
12
﹤0.01% 501
2019
Q2
$1K Hold
12
﹤0.01% 481
2019
Q1
$1K Hold
12
﹤0.01% 479
2018
Q4
$1K Hold
12
﹤0.01% 475
2018
Q3
$1K Hold
12
﹤0.01% 508
2018
Q2
$1K Hold
12
﹤0.01% 519
2018
Q1
$1K Hold
12
﹤0.01% 543
2017
Q4
$1K Hold
12
﹤0.01% 547
2017
Q3
$1K Hold
12
﹤0.01% 550
2017
Q2
$0 Hold
12
﹤0.01% 562
2017
Q1
$0 Hold
12
﹤0.01% 561
2016
Q4
$0 Hold
12
﹤0.01% 545
2016
Q3
$0 Hold
12
﹤0.01% 542
2016
Q2
$0 Hold
12
﹤0.01% 568
2016
Q1
$0 Hold
12
﹤0.01% 481
2015
Q4
$0 Buy
+12
New +$373 ﹤0.01% 480
2015
Q1
Sell
-59
Closed -$3K 425
2014
Q4
$3K Buy
+59
New +$2.32K ﹤0.01% 406

Other funds holding AVNS

City Holding Co's AVNS Position: Q1 2023 in Review

City Holding Co sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 12 shares — an estimated $324 sold.

City Holding Co first reported a position in AVNS in Q4 2014 and held it in 30 quarters. The position peaked at $3K in Q4 2014. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

  • City Holding Co reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
  • City Holding Co sold 12 Avanos Medical shares in Q1 2023, an estimated $324.
  • City Holding Co first reported a position in Avanos Medical in Q4 2014 and held it in 30 quarters.
  • City Holding Co's Avanos Medical position peaked at $3K in Q4 2014.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on City Holding Co's 13F filing for Q1 2023, filed 17 Apr 2023.